Former Netchemia CEO, KC venture capitalist launch new fund for Midwest software firms

February 1, 2018  |  Bobby Burch

Keith Harrington and Carlos Antequera, Novel Growth Partners

Keith Harrington isn’t looking for hockey-stick growth companies.

With the new fund he’s co-leading — Novel Growth Partners — Harrington wants to invest in small, steadily-growing tech companies in the Midwest. But instead of a traditional venture capital model, Novel is employing a revenue-based finance model that should appeal to more entrepreneurs, Harrington said.

“We believe that the current financing ecosystem excludes the majority of companies seeking financing. We know that only a small percentage of companies get venture capital and most young companies are too small for private equity and can’t get meaningful bank financing,” said Harrington, a former managing director at Kansas Bioscience Authority and recent Kauffman Fellow graduate. “We also recognize that there is a very large set of early-stage companies with revenue and growth that can benefit from the unique combination of capital and operational expertise we deploy.”

Harrington partnered with former Netchemia CEO Carlos Antequera to launch the fund. Antequera’s former firm sold to Vista Equity Partners in 2015.

With decades of business experience, the duo was inspired by challenges they recognized in firms’ ability to attract the appropriate type of funding — particularly in markets with limited access early-stage capital.

Here’s how Novel’s royalty-like model works:

Instead of taking portfolio company’s equity — thus requiring it to sell to generate a large return on the investment — Novel’s investment gets paid back at a set monthly percentage of the company’s revenue. The percentage is usually between 4 and 8 percent of the portfolio firm’s monthly revenue up to a predetermined return cap of up to five years. Novel provides developing software companies $100,000 to $500,000 in growth capital.

As a result, the entrepreneur is able to preserve ownership while growing the value of the company.

Novel plans to further add value to its portfolio firms by offering a boot camp focused on identifying and executing specific projects to accelerate revenue growth, Antequera said. During the boot camp, Novel props up new systems, automates processes and helps identify talent that will accelerate sales, Antequera said.

“We’re on a mission to provide capital to companies that have some revenue, customers and are focused on improving their business fundamentals, but in addition to capital, need improved sales systems, processes and talent to grow,” said Antequera. “Because venture requires rapid scaling, it is not the right type of capital for many companies. Equity venture investors cannot fund slow-growth opportunities. That’s where we come in, our model allows us to provide capital to companies with steady growth.”

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

2018 Startups to Watch

    stats here

    Related Posts on Startland News

    Andy Page and David Alburty, InnovaPrep

    ‘Never used like this before’: KC-built biosurveillance, sensor tech, disinfectant firms poised for team COVID-19 battle

    By Tommy Felts | March 29, 2020

    Editor’s note: The following is part of Startland News’ ongoing coverage of the impact of Coronavirus (COVID-19) on Kansas City’s entrepreneur community, as well as how innovation is helping to drive a new normal in the ecosystem. Click here to follow related stories as they develop. Kansas City companies are expected to play a role on…

    Hyleme George, IgniteX accelerator

    LaunchKC, Black & Veatch open COVID-19 grants competition with $250K (or more) for startups

    By Tommy Felts | March 28, 2020

    Editor’s note: The following is part of Startland News’ ongoing coverage of the impact of Coronavirus (COVID-19) on Kansas City’s entrepreneur community, as well as how innovation is helping to drive a new normal in the ecosystem. Click here to follow related stories as they develop. A newly announced grants competition could boost both the health…

    COVID-19, Fusion Medical Animation

    Biotech firm seeks to advance novel exosome isolation-based therapy for COVID-19 into clinical trials

    By Tommy Felts | March 28, 2020

    Editor’s note: The following is part of Startland News’ ongoing coverage of the impact of Coronavirus (COVID-19) on Kansas City’s entrepreneur community, as well as how innovation is helping to drive a new normal in the ecosystem. Click here to follow related stories as they develop. As the global Coronavirus (COVID-19) outbreak grows, Clara Biotech is…

    LEANLAB: Homebound KC students need $4.6M in tech, WiFi hotspots to bridge digital divide amid Coronavirus creep

    By Tommy Felts | March 27, 2020

    Editor’s note: The following is part of Startland News’ ongoing coverage of the impact of Coronavirus (COVID-19) on Kansas City’s entrepreneur community, as well as how innovation is helping to drive a new normal in the ecosystem. Click here to follow related stories as they develop. Kansas City has long talked about the impact of a…